On October 12, 2023, the Shanghai Municipal Commission of Science and Technology officially announced the list of "the second batch of high-tech enterprises to be recognized in Shanghai in 2023". Links was listed and awarded the title of high-tech enterprise, marking our outstanding performance in the field of medical devices being officially recognized.
To promote technological innovation, industrial upgrading, economic growth, and the improvement of national independent innovation capabilities, China has always attached great importance to and strictly regulated the recognition of high-tech enterprises. After being first recognized as a high-tech enterprise in 2020, Links passed the re-examination on October 12, 2023, and was once again recognized as a high-tech enterprise. This recognition not only affirms our unremitting efforts but also recognizes our important contributions in the field of medical device innovation.
In the future, Links will continue to innovate and promote the research and development of clinical trials for high-risk and implantable medical devices, to support more domestic and foreign medical device enterprises in promoting the process of product marketization. We firmly believe that technology and innovation are the driving forces behind the industry's progress, and we will continue to make greater contributions to the future of the medical device industry.
LINKS CRO
As a CRO company providing clinical trial services. LINKS CRO focus on innovation, high-risk implantation(intervention) medical device, with one-stop clinical trial solutions for the whole process of medical device research and development.The headquarters of LINKS is based in Shanghai, with subsidiary branches in Beijing, Shanghai, Guangzhou, and Shenzhen, in addition to ten regional offices. The current workforce comprises almost 200 employees, with technical personnel making up over 85% and dispersed across almost 30 cities nationwide. Key Services include CRO, SMO, CER, Audit, Post-market research, core laboratory registration both domestically and overseas, innovation declaration, Expert Consultancy, and overseas enterprise agency services. Key Indications include Cardiovascular, Neurovascular, Peripheral Vascular, Surgery Robot, Oncology, Ophthalmology, Medical Cosmetology, and other fields such as orthopedics. There are almost 300 projects consultations and services by LINKS each year.
